Young CEO Martin Shkerli has been known for his success at a young age, but his success hasn’t exactly come without a price. That is, a price for people with life-threatening illnesses such as AIDS or cancer. Daraprim, a drug that is used by these patients, used to be $13.50 per pill, which is still very pricey. Shkerli raised the price to $750 a pill in just one night. His actions are obviously abominable and he has even been called out by Hillary Clinton. He has been anything but apologetic, as he responded to criticism from the media by implying that they should take a look at his middle finger.
The other thing that needs to be taken into consideration is the fact that many cancer or AIDS patients need to take multiple drugs a day. In that case, even if they could afford the Daraprim, there are many other drugs that they need to pay for in order to be able to live. I can take a wild guess that their insurance isn’t going to pay for most of those expensive drugs, so the rest needs to come out-of-pocket.
Even though this story has recently come out in the news, I am sure it is not the first time this has happened. I wouldn’t be surprised if some companies take advantage of patients by skyrocketing the price of medications. After all, these medications are made primarily for businesses to make money and although they do help people, it is important to keep that in mind.